Human Papillomavirus: Vaccination

Department of Health and Social Care written question – answered on 9th January 2019.

Alert me about debates like this

Photo of Sharon Hodgson Sharon Hodgson Shadow Minister (Public Health)

To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the effect of the men who have sex with men (MSM) vaccination programme on the incidence of HPV-related diseases in MSM.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The national human papillomavirus (HPV) vaccination programme for men who have sex with men (MSM) began on 1 April 2018 and is being introduced via a phased roll out in all sexual health and human immunodeficiency virus clinics across England. As this programme can span up to two years, and some HPV-related diseases (i.e. cancers) take years to develop following infection, the full impact of this vaccination programme on the incidence of diseases will not be fully seen for many years. However, data is being collected to monitor the impact on diagnoses of anogenital warts and on the prevalence of HPV infection in MSM. It is expected that this will provide the earliest assessment of the initial effects of the programme in 2019/20.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.